The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Well polygon and co , seem to have a game plan , polar and co must be concerned,
the SP is your normal Aim peaks and troughs, it would be nice to know US data
Causing a lot of speculation, I bought at 175 so have enjoyed the last few weeks.
Just hope we are not short changed , RM he said this drug works.
My last rant for today,
I bought at 175 love the banter, keeps me going 70 next year , I’m waiting for the data from the US trial . Which hopefully will give mankind a decent antiviral. Bought at 175 watched it fall to 85 another bottom drawer I thought ,,leave it in the WILL and here we are good results next fence to jump , happy days
Rumania problems and new Delta variant, death toll up ,this is not going away . Urgent vaccination
3 rd booster required urgent , we are going to need antivirals , this winter soon as
The monetary cost in research into interferon world wide far exceeds this share price, synairgen Southampton team must be sitting on a fortune in data and years ahead of it’s peers
It can cost up to $1200 before you can make profit per oz of gold , work force utilities etc.
Energy biggest cost. Gold price bouncing about , inflation ,COVID , affecting share price
Great company , who own there own drilling kit